![Jacqueline Shea](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jacqueline Shea
Directeur Général chez
INOVIO PHARMACEUTICALS, INC.
Fortune : 122 123 $ au 30/06/2026
Profil
Jacqueline E.
Shea is President, Chief Executive Officer & Director at Inovio Pharmaceuticals, Inc. since 2022 and Trustee at Albert B. Sabin Vaccine Institute, Inc. since 2019.
Formerly, Dr. Shea was Chief Executive Officer at Aeras Global TB Vaccine Foundation from 2015 to 2018, Vice President-Europe Business Development at Emergent BioSolutions, Inc. from 2013 to 2014, and Vice President & General Manager at The Oxford-Emergent Tuberculosis Consortium Ltd. from 2008 to 2013.
Education includes undergraduate studies at the University of Bath and a doctorate from The National Institute For Medical Research.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/05/2026 | 111 021 ( 0,13 % ) | 122 123 $ | 30/06/2026 |
Postes actifs de Jacqueline Shea
| Sociétés | Poste | Début |
|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Directeur Général | 10/05/2022 |
Albert B. Sabin Vaccine Institute, Inc.
 Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Creates solutions to health threats | Directeur/Membre du Conseil | 13/08/2019 |
Anciens postes connus de Jacqueline Shea
| Sociétés | Poste | Fin |
|---|---|---|
Aeras Global TB Vaccine Foundation
 Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Directeur Général | 01/12/2018 |
| EMERGENT BIOSOLUTIONS INC. | Corporate Officer/Principal | 01/03/2014 |
The Oxford-Emergent Tuberculosis Consortium Ltd.
 The Oxford-Emergent Tuberculosis Consortium Ltd. BiotechnologyHealth Technology Develops advanced vaccine for the prevention of tuberculosis | Corporate Officer/Principal | 01/01/2013 |
Formation de Jacqueline Shea
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Aeras Global TB Vaccine Foundation
Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Commercial Services |
Albert B. Sabin Vaccine Institute, Inc.
Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Creates solutions to health threats | Commercial Services |
University of Bath
 University of Bath Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inovio Pharmaceuticals, Inc.
 Inovio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops synthetic vaccines and immune therapies for cancers and infectious diseases | Health Technology |
Emergent BioSolutions, Inc.
 Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
The National Institute For Medical Research
 The National Institute For Medical Research Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Oxford-Emergent Tuberculosis Consortium Ltd.
The Oxford-Emergent Tuberculosis Consortium Ltd. BiotechnologyHealth Technology Develops advanced vaccine for the prevention of tuberculosis | Health Technology |
